There are different generations in GcMAF therapy. The first generation GcMAF was developed over 20 years ago. Due to limited testing and clinical uses, the efficacy is unknown.
GcMAF treatment is a highly effective macrophage activating therapy, used to stimulate the immune system and activate macrophages so that they can destroy cancer cells and other abnormal cells in the body.
For the treatment for Autism Spectrum Disorders (ASD) and immune system diseases.